PharmSci 360

PharmSci 360 Scientific Programming Committee


Kevin Litwiler, Ph.D., Pfizer (Chair)

Otilia Koo, Ph.D., BMS (Vice Chair)

Mark Arnold, Ph.D., FAAPS, Labcorp (Past Chair)

Faye Vazvaei-Smith, M.S., Merck (AAPS Board of Directors Liaison)
 

Discovery and Basic Research Track

Tamer Fandy, Ph.D., University of Charleston (Track Chair)

Zhenzhen Dong, Ph.D., MSc, Adesis, Inc. (Sub-Track Leader, Biomolecular)

Rick Gemeinhart, Ph.D., University of Illinois Chicago (Sub-Track Leader, Chemical)

Preclinical Development Track

Jae Chang, Ph.D., ORIC Pharmaceuticals (Track Chair)

Naveen Thakral, Ph.D., Boehringer Ingelheim Pharmaceuticals, Inc. (Sub-Track Leader, Biomolecular)

Yasuhiro Tsume, Ph.D. Merck (Sub-Track Leader, Chemical)

Bioanalytics Track

Amanda Hays, Ph.D., BioAgilytix (Track Chair)

William Hallett, Ph.D., Janssen (Sub-Track Leader, Biomolecular)

Matthew Halquist, Ph.D., Virginia Commonwealth University (Sub-Track Leader, Chemical)

Clinical Pharmacology Track

Amit Desai, Ph.D., Astellas Pharma (Track Chair)

Galina Bernstein, Ph.D., Camargo Pharmaceutical Services (Sub-Track Leader, Biomolecular)

Vaishali Sahasrabudhe, Ph.D., Pfizer (Sub-Track Leader, Chemical)

Manufacturing and Analytical Characterization Track

Narayan Variankaval, Ph.D., Merck (Track Chair)

Sayantan Chattoraj, Ph.D., GlaxoSmithKline (Sub-Track Leader, Biomolecular)

Maria Cruanes, Ph.D., Organon (Sub-Track Leader, Chemical)

Formulation and Delivery Track

Nikoletta Fotaki, Ph.D., FAAPS, University of Bath (Track Chair)

Shuhua Bai, Ph.D., Husson University (Sub-Track Leader, Biomolecular)

Jaymin Shah, Ph.D., Pfizer (Sub-Track Leader, Chemical)